PALI logo

Palisade Bio (PALI)

Profile

Full Name

Palisade Bio, Inc.

Ticker Symbol

PALI

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

March 30, 2007

Indexes

Not included

Website

http://www.palisadebio.com

Employees

8

Key Details

Price

$0.72(+2.86%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$10.19(+62.27% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.72
PALI price is $0.72

30-Day Relative Volume

0.10
PALI 30-day relative volume is 0.10

Price Performance

Price Most recent change

+2.86%
PALI price was up +2.86% on Apr 17, 2025

Price YTD change

-56.36%
PALI price is down -56.36% since January 1st

Price 1-year change

-89.09%
PALI price is down -89.09% year-on-year

Price 3-year change

-99.9%
PALI price is down -99.9% over the past 3 years

Price Range

Price All-time high

$8182.50
PALI price is currently -99.99% below its historical high of $8182.50

Price 3-year low

$0.60
PALI price is currently +20.00% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$3.31M
PALI market capitalization is $3.31 million

Market cap 3-year change

-97.88%
PALI market capitalization is down -97.88% over the past 3 years

Market cap All-time high

$962.52M
PALI market capitalization is currently -99.66% below its historical high of $962.52 million

Market cap sector rank

9.55%
PALI market capitalization is higher than 9.55% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+337.19%
PALI shares outstanding is up +337.19% year-on-year

Shares Outstanding 3-Year Change

+1949.31%
PALI shares outstanding is up +1949.31% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.41
PALI beta is 0.41

200-day SMA

$2.45
PALI price is currently -70.64% below its 200-day simple moving average

50-day SMA

$0.84
PALI price is currently -14.57% below its 50-day simple moving average

RSI

45.48
PALI 14-day relative strength index is 45.48

Volume

0.10
PALI 30-day relative volume is 0.10

ATR

$0.06
PALI average true range is $0.06

10-day Historical Volatility

78.93%
PALI 10-day historical volatility is 78.93%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
PALI annual revenue value is unknown

Revenue Analysts estimate

-
PALI annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
PALI annual revenue 1-year change is unknown

Revenue Sector rank

-
PALI annual revenue is unknown

EPS

EPS

-$10.19
PALI annual earnings per share is -$10.19

EPS Analysts estimate

-$2.00
PALI annual earnings per share is currently +408.23% higher than the consensus analysts' forecast

EPS 1-year change

+62.27%
PALI annual earnings per share is up +62.27% year-on-year

EPS Sector rank

12.03%
PALI annual earnings per share is higher than 12.03% of companies in Healthcare sector

Profit

Gross profit

-
PALI annual gross profit value is unknown

Gross margin

-
PALI annual gross profit margin value is unknown

Operating profit

-$14.86M
PALI annual operating income is -$14.86 million

Operating margin

-
PALI annual operating profit margin value is unknown

Net income

-$14.44M
PALI annual net profit is -$14.44 million

Net margin

-
PALI annual net profit margin value is unknown

Expenses

Total expenses

$14.86M
PALI annual total expenses is $14.86 million

Operating expenses

$14.86M
PALI annual total operating expenses is $14.86 million

Cost of goods sold

-
PALI annual cost of goods sold value is unknown

Selling, general & administrative expenses

$5.80M
PALI annual SGA is $5.80 million

Depreciation and amortization

$3000.00
PALI annual depreciation & amortization is $3000.00

Interest expense

$12.00K
PALI annual interest expense is $12.00 thousand

Income tax

-
PALI annual income tax value is unknown

EBIT & EBITDA

EBIT

-$14.43M
PALI annual earnings before interest & taxes is -$14.43 million

EBITDA

-$14.42M
PALI annual EBITDA is -$14.42 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$10.88M
PALI annual total assets is $10.88 million

Non current assets

$386.00K
PALI annual long term assets is $386.00 thousand

Current assets

$10.49M
PALI annual total current assets is $10.49 million

Cash and cash equivalents

$9.82M
PALI annual cash & cash equivalents is $9.82 million

Accounts receivable

-
PALI annual accounts receivable value is unknown

Inventory

-
PALI annual inventory value is unknown

Liabilities

Total liabilities

$3.39M
PALI annual total liabilities is $3.39 million

Long term liabilities

$152.00K
PALI annual total long term liabilities is $152.00 thousand

Current liabilities

$3.24M
PALI annual total current liabilities is $3.24 million

Accounts payable

$1.21M
PALI annual accounts payable is $1.21 million

Debt

Total debt

$169.00K
PALI annual total debt is $169.00 thousand

Total debt 1-year change

-54.2%
PALI annual total debt is down -54.2% year-on-year

Long term debt

$0.00
PALI annual long term debt is $0.00

Short term debt

$169.00K
PALI annual short term debt is $169.00 thousand

Equity & Capital

Shareholders equity

$7.49M
PALI annual stockholders equity is $7.49 million

Book value

$7.49M
PALI annual book value is $7.49 million

Retained earnings

-$135.94M
PALI annual retained earnings is -$135.94 million

Working capital

$7.26M
PALI annual working capital is $7.26 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$12.19M
PALI annual cash flow from operations is -$12.19 million

Cash from operations 1-year change

-9.52%
PALI annual cash flow from operations is down -9.52% year-on-year

Cash from investing

$0.00
PALI annual cash flow from investing activities is $0.00

Cash from investing 1-year change

+100%
PALI annual cash flow from investing activities is up +100% year-on-year

Cash from financing

$9.58M
PALI annual cash flow from financing activities is $9.58 million

Cash from financing 1-year change

-14.34%
PALI annual cash flow from financing activities is down -14.34% year-on-year

CAPEX

CAPEX

-
PALI annual capital expenditures value is unknown

CAPEX 1-year change

-
PALI annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$12.19M
PALI annual free cash flow is -$12.19 million

Free cash flow 1-year change

-9.48%
PALI annual free cash flow is down -9.48% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
PALI annual gross profit margin value is unknown

Operating margin

-
PALI annual operating profit margin value is unknown

Net margin

-
PALI annual net profit margin value is unknown

ROA & ROE

ROA

-132.70%
PALI annual return on assets is -132.70%

ROE

-192.71%
PALI annual return on equity is -192.71%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
PALI price to earnings ratio value is unknown

PE ratio Sector rank

-
PALI price to earnings ratio is unknown

PB Ratio

PB ratio

0.44
PALI price to book ratio is 0.44

PB ratio Sector rank

27.86%
PALI price to book ratio is higher than 27.86% of companies in Healthcare sector

PS Ratio

PS ratio

-
PALI price to sales ratio value is unknown

PS ratio Sector rank

-
PALI price to sales ratio is unknown

Enterprise value

Enterprise value

-$6.34M
PALI enterprise value is -$6.34 million

Enterprise value Sector rank

5.96%
PALI enterprise value is higher than 5.96% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

0.44
PALI EV/EBITDA is 0.44

EV/EBITDA Sector rank

71.78%
PALI EV/EBITDA is higher than 71.78% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

3.24
PALI annual current ratio is 3.24

Quick ratio

-
PALI annual quick ratio value is unknown

Leverage

Debt to equity

0.02
PALI annual debt to equity ratio is 0.02

Interest coverage ratio

-1202.17
PALI annual interest coverage ratio is -1202.17

Risk & Stability

Piotroski F-Score

-
PALI piotroski f-score value is unknown

Altman Z-Score

-
PALI altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Nov 20, 24 Brookline Capital
Buy
Nov 13, 24 Maxim Group
Buy
May 1, 24 Maxim Group
Buy
Apr 16, 24 Maxim Group
Buy
Nov 17, 23 Maxim Group
Buy
May 16, 23 Ladenburg Thalmann
Buy
Mar 30, 23 Maxim Group
Buy
Aug 19, 22 Maxim Group
Hold
Feb 2, 22 Ladenburg Thalmann
Buy
Aug 31, 21 Maxim Group
Buy

Institutional Ownership

Similar stocks

INM logo
InMed Pharmaceuticals (INM)
QNRX logo
Quoin Pharmaceuticals (QNRX)
GLTO logo
Galecto (GLTO)
EVOK logo
Evoke Pharma (EVOK)
TTNP logo
Titan Pharmaceuticals (TTNP)
ATNF logo
180 Life Sciences (ATNF)
ARTL logo
Artelo Biosciences (ARTL)
NBY logo
NovaBay Pharmaceuticals (NBY)
RSLS logo
ReShape Lifesciences (RSLS)
  • What is the ticker symbol for Palisade Bio?
  • Does Palisade Bio pay dividends?
  • What sector is Palisade Bio in?
  • What industry is Palisade Bio in?
  • What country is Palisade Bio based in?
  • When did Palisade Bio go public?
  • Is Palisade Bio in the S&P 500?
  • Is Palisade Bio in the NASDAQ 100?
  • Is Palisade Bio in the Dow Jones?
  • When was Palisade Bio's last earnings report?
  • When does Palisade Bio report earnings?
  • Should I buy Palisade Bio stock now?

What is the ticker symbol for Palisade Bio?

The ticker symbol for Palisade Bio is NASDAQ:PALI

Does Palisade Bio pay dividends?

No, Palisade Bio does not pay dividends

What sector is Palisade Bio in?

Palisade Bio is in the Healthcare sector

What industry is Palisade Bio in?

Palisade Bio is in the Biotechnology industry

What country is Palisade Bio based in?

Palisade Bio is headquartered in United States

When did Palisade Bio go public?

Palisade Bio's initial public offering (IPO) was on March 30, 2007

Is Palisade Bio in the S&P 500?

No, Palisade Bio is not included in the S&P 500 index

Is Palisade Bio in the NASDAQ 100?

No, Palisade Bio is not included in the NASDAQ 100 index

Is Palisade Bio in the Dow Jones?

No, Palisade Bio is not included in the Dow Jones index

When was Palisade Bio's last earnings report?

Palisade Bio's most recent earnings report was on Aug 15, 2022

When does Palisade Bio report earnings?

The date for Palisade Bio's next earnings report has not been announced yet

Should I buy Palisade Bio stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page